Pfizer and BioNTech to seek approval of booster dose for those aged 16 to 17

Pfizer and BioNTech are expected to seek authorization this week for a Covid-19 vaccine booster for teens 16 and 17 years old, Report informs, citing foreign media.

If approved, the additional Pfizer-BioNTech shot would mark the first vaccine booster for teens younger than 18.

The move comes as a new variant of coronavirus, known as omicron, spreads around the globe, worrying experts and pushing President Joe Biden to urge caution and again implore Americans to get inoculated.